Literature DB >> 7542631

Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

R K Gupta1, W Egan, D A Bryla, J B Robbins, S C Szu.   

Abstract

Escherichia coli O111, of various H types and virulence factors, causes enteritis throughout the world, especially in young children. This O type is found rarely in healthy individuals. Serum antibodies to the O-specific polysaccharide of O111 lipopolysaccharide (LPS) protect mice and dogs against infection with this E. coli serotype. The O111 O-specific polysaccharide is composed of a pentasaccharide repeat unit with two colitoses bound to the C-3 and C-6 of glucose in a trisaccharide backbone; this structure is identical to that of Salmonella adelaide (O35), another enteric pathogen. Nonpyrogenic O111 O-specific polysaccharide was prepared by treatment of its LPS with acetic acid (O-SP) or the organic base hydrazine (DeA-LPS). The O-SP had a reduced concentration of colitose. These products were derivatized with adipic acid dihydrazide (ADH) or thiolated with N-succinimidyl-3(2-pyridyldithio) propionate (SPDP). The four derivatives were covalently bound to tetanus toxoid (TT) by carbodiimide-mediated condensation or with SPDP to form conjugates. Immunization of BALB/c and general-purpose mice by a clinically acceptable route showed that DeA-LPS-TTADH, of the four conjugates, elicited the highest level of LPS antibodies. Possible reasons to explain this differential immunogenicity between the four conjugates are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542631      PMCID: PMC173380          DOI: 10.1128/iai.63.8.2805-2810.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Isolation of colitose-containing oligosaccharides from the cell wall lipopolysaccharide of Escherichia coli.

Authors:  R D Edstrom; E C Heath
Journal:  Biochem Biophys Res Commun       Date:  1965-12-21       Impact factor: 3.575

2.  Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2.

Authors:  R C Goldman; L Leive
Journal:  Eur J Biochem       Date:  1980

3.  Escherichia coli serogroup O111 includes several clones of diarrheagenic strains with different virulence properties.

Authors:  L C Campos; T S Whittam; T A Gomes; J R Andrade; L R Trabulsi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

5.  Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors:  D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

6.  Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.

Authors:  C Chu; R Schneerson; J B Robbins; S C Rastogi
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum.

Authors:  R C Goldman; D White; F Orskov; I Orskov; P D Rick; M S Lewis; A K Bhattacharjee; L Leive
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

8.  Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.

Authors:  V Y Polotsky; J B Robbins; D Bryla; R Schneerson
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.

Authors:  K A Joiner; M A Schmetz; R C Goldman; L Leive; M M Frank
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.

Authors:  R C Goldman; K Joiner; L Leive
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

View more
  6 in total

1.  Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.

Authors:  Satoshi Ishikawa; Kazuyoshi Kawahara; Yutaka Kagami; Yasunori Isshiki; Aki Kaneko; Hidenori Matsui; Nobuhiko Okada; Hirofumi Danbara
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages.

Authors:  Melha Mellata; Maryvonne Dho-Moulin; Charles M Dozois; Roy Curtiss; Brigitte Lehoux; John M Fairbrother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.

Authors:  Zhigang Jin; Gregory A Bohach; Joseph Shiloach; Scott E Norris; Darón I Freedberg; Claudia Deobald; Bruce Coxon; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.

Authors:  Maurílio F Santos; Roger R C New; Gabrielle R Andrade; Christiane Y Ozaki; Osvaldo A Sant'Anna; Lucia Mendonça-Previato; Luis R Trabulsi; Marta O Domingos
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

5.  Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid.

Authors:  Faezeh Najafzadeh; Ghazaleh Jaberi; Reza Shapouri; Mehdi Rahnema; Ashraf Karimi-Nik; Anvarsadat Kianmehr
Journal:  Iran J Microbiol       Date:  2014-10

6.  A universal polysaccharide conjugated vaccine against O111 E. coli.

Authors:  Gabrielle R Andrade; Roger R C New; Osvaldo A Sant'Anna; Neil A Williams; Rosely C B Alves; Daniel C Pimenta; Hugo Vigerelli; Bruna S Melo; Letícia B Rocha; Roxane M F Piazza; Lucia Mendonça-Previato; Marta O Domingos
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.